Overview

• Over 806 applications have been approved across 14 sectors under the Production Linked Incentive scheme as of July 2025.
• Investments of ₹1.76 lakh crore realised by March 2025 have driven incremental production worth ₹16.5 lakh crore and created more than 12 lakh direct and indirect jobs.
• Pharmaceutical sector sales hit ₹2.66 lakh crore including ₹1.7 lakh crore in exports, converting India into a net exporter of bulk drugs.
• Mobile exports grew 775% between 2020-21 and 2024-25 to reach ₹2 lakh crore, marking a sharp decline in import dependence.
• Forty-eight bulk-drug projects were approved to scale up domestic KSM, DI and API manufacturing and avoid ₹1,362 crore in imports.